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Trinucleotide repeat (TNR) expansions are present in a wide range of genes involved in sev-
eral neurological disorders, being directly involved in the molecular mechanisms underlying
pathogenesis through modulation of gene expression and/or the function of the RNA or
protein it encodes. Structural and functional information on the role of TNR sequences in
RNA and protein is crucial to understand the effect of TNR expansions in neurodegenera-
tion.Therefore, this review intends to provide to the reader a structural and functional view
ofTNR and encoded homopeptide expansions, with a particular emphasis on polyQ expan-
sions and its role at inducing the self-assembly, aggregation and functional alterations of
the carrier protein, which culminates in neuronal toxicity and cell death. Detail will be given
to the Machado-Joseph Disease-causative and polyQ-containing protein, ataxin-3, provid-
ing clues for the impact of polyQ expansion and its flanking regions in the modulation of
ataxin-3 molecular interactions, function, and aggregation.
Keywords: amino acid-repeats, microsatellites, protein complexes, protein aggregation, amyloid, protein structure
TRINUCLEOTIDE REPEATS AND HUMAN DISEASE
Trinucleotide repeat (TNR) expansions and their association with
neurological disorders have been known for the past 20 years
(La Spada et al., 1991). Expansion of CAG, GCG, CTG, CGG,
and GAA repeats located in coding or non-coding sequences of
different genes (summarized in Table 1; Figures 1 and 2) are asso-
ciated with a diverse range of human monogenic diseases such
as Spinobulbar Muscular Atrophy (SBMA, a.k.a. Kennedy dis-
ease), Huntington Disease (HD), Spinocerebellar Ataxias (SCAs),
Oculopharyngeal Muscular Dystrophy (OPMD), Myotonic Type 1
(DM1), Fragile X-Associated Tremor Ataxia Syndrome (FXTAS),
and Friedreich Ataxia (FRDA) (for a review see Orr and Zoghbi,
2007), with longer repeats being correlated with earlier age at onset
and increased disease severity. These TNR are highly unstable
and the repeat tract length can change between affected indi-
viduals within the same family and can be different in different
tissues (La Spada, 1997; Brouwer et al., 2009). More interestingly,
in the brain of patients affected by CAG expansions, differences
in repeat instability have been found between specific cell types
(Pearson et al., 2005; Gonitel et al., 2008; Lopez Castel et al.,
2010). GCG repeats are usually shorter and reveal a higher sta-
bility in different tissues and across generations than CAG repeats.
The dynamic nature of these DNA repeat expansions is a con-
sequence of their capability to form different secondary struc-
tures, which interfere with the cellular mechanisms of replication,
repair, recombination and transcription (for a recent review see
Lopez Castel et al., 2010). The molecular mechanisms underly-
ing pathogenesis in those disorders, either associated with mental
retardation, neuronal, or muscular degeneration, might result
from alterations in the levels of gene expression and/or the func-
tion of the RNA or protein it encodes, mechanisms that likely
act in concert to influence the pattern of selective cell toxic-
ity. Some of those toxicity mechanisms will be briefly discussed
below.
TRINUCLEOTIDE REPEATS AND RNA STRUCTURE
The formation of hairpin structures within the TNR RNA is related
to the gain in RNA toxic function, the major pathogenic mecha-
nism associated with CUG and CGG repeat expansions in non-
coding regions of DM1 and FXTAS transcripts, which was also
shown to contribute to pathogenesis in CAG repeat disorders such
as HD and Machado-Joseph disease (MJD, a.k.a. SCA3) (reviewed
in Krzyzosiak et al., 2012). These duplex structures, whose sta-
bility is positively correlated with the repeat size (Napierala and
Krzyzosiak, 1997), sequester dsRNA binding proteins involved in
mRNA splicing such as CUG-binding protein (CUGBP) and mus-
cleblind protein 1 (MBNL1) (Miller et al., 2000), inducing aber-
rant splicing in affected cells, compromising multiple intracellular
pathways, affecting cell-quality control regulation, and ultimately
resulting in cell dysfunction (Li and Bonini, 2010). Structural stud-
ies on model trinucleotide CUG, CAG, and CGG repeats forming
double-stranded chains revealed the features induced by peri-
odic U-U, A-A, and G-G mismatches, and provided hints into the
structural details of pathogenic RNAs that are recognized by RNA-
binding proteins (Mooers et al., 2005; Kiliszek et al., 2010, 2011;
Kumar et al., 2011; Parkesh et al., 2011). MBNL1 is composed
of four zinc-containing RNA-binding domains arranged in two
tandem segments, with the C-terminal zinc-finger pair displaying
a GC-sequence recognition motif (Teplova and Patel, 2008) and
interacting with the stem region of expanded CUG RNAs (Yuan
et al., 2007). Electron microscopy analysis of MBNL1:CUG136
complexes showed that the pathogenic dsRNA forms a scaffold
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Almeida et al. Structure and function of trinucleotide repeats
FIGURE 1 | Structural variability of proteins encoded byTNR-containing
genes. Illustrative domain graphics of the multi-domain structure of proteins
associated with polyQ-expansion diseases. All proteins shown are
referenced by their name as annotated in UniProt. The protein domains for
which information is annotated in the Pfam database are shown as colored
boxes with Pfam family accession code referenced above the domain box.
Complete names of domains can be assessed by searching the specific
Pfam accession code at http://pfam.sanger.ac.uk/. Numbers below the
domain schemes represent amino acid residue numbers. Regions
containing the amino acid repeats and with a prediction for formation of
coiled-coils (as annotated in UniProt) are shown as well as regions with
known 3D structure (boxed in red, with PDB accession codes shown).
Notice the predominant location of the repeat regions within the N-terminal
regions of the proteins.
with tandem spaced MBNL1 binding sites were MBNL1 oligomers
with a ring-like structure can assemble, possibly leading to the for-
mation of the ribonuclear foci identified in cell models of these
TNR diseases (Yuan et al., 2007; de Mezer et al., 2011). The struc-
ture and stability of the TNR hairpin structures formed depends on
the presence of interruptions as well as on the nature of the flank-
ing regions. This might be related with the ability of individual
repeats to participate in the RNA toxicity mechanisms (Krzyzosiak
et al., 2012).
In FRDA and FXTAS, pathogenesis results predominantly
from decreased expression of the associated genes (FXN and
FMR1/FMR2) caused by the expansion of GAA and CGG repeats,
respectively, which results in loss of function of key proteins
involved in iron-sulfur cluster biogenesis and mRNA translation
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FIGURE 2 | Structural variability of proteins encoded by
TNR-containing genes. Illustrative domain graphics of the multi-domain
structure of proteins associated with polyD- and polyA-expansion diseases.
All proteins shown are referenced by their name as annotated in UniProt.
The protein domains for which information is annotated in the Pfam
database are shown as colored boxes with Pfam family accession code
referenced above the domain box. Complete names of domains can be
assessed by searching the specific Pfam accession code at
http://pfam.sanger.ac.uk/. Numbers below the domain schemes represent
amino acid residue numbers. Regions containing the amino acid repeats
and with a prediction for formation of coiled-coils (as annotated in UniProt)
are shown as well as regions with known 3D structure (boxed in red, with
PDB accession codes shown). Notice the predominant location of the
repeat regions within the N-terminal regions of the proteins.
at synapses. Nevertheless, in FXTAS RNA toxicity is also proposed
to play a role in pathogenesis (Li and Bonini, 2010). The recently
discovered mechanisms of pathogenesis in spinocerebellar ataxia
type 8 (SCA8) uncovered the extreme complexity of TNR disor-
ders. In fact, SCA8 is caused by expansion of CTG/CAG repeats
in the affected gene, which are transcribed bi-directionally leading
to the generation of expanded CUG and CAG-containing tran-
scripts further translated into homopolymeric proteins, so that
pathogenesis can be mediated by both RNA and protein toxicity
(Merienne and Trottier, 2009). Curiously, recent data have high-
lighted the possibility of non-ATG translation across expanded
TNR in all possible reading frames, which might further con-
tribute to the generation of novel toxic proteins and RNAs adding
to the multi-parametric character of the pathogenic mechanisms
associated with TNR diseases (Li and Bonini, 2010; Pearson, 2011;
Sicot et al., 2011).
TRINUCLEOTIDE REPEATS WITHIN PROTEIN CODING REGIONS
Over 20 years ago, the finding that the expansion of CAG repeats
within the coding sequence of the androgen receptor gene was the
genetic basis of SBMA (La Spada et al., 1991) represented a hall-
mark in the discovery of these novel dynamic mutations and their
association with human disease. Some years later, the identifica-
tion of intracellular inclusions containing the expanded proteins
(Paulson et al., 1997) provided a clue to pathogenesis, directing
research in the field into an extensive search for the mechanisms
of polyQ-induced protein aggregation. The moderate expansion
of GCG and CAG repeats, which are translated into polyA and
polyQ tracts in the affected proteins (Figures 1 and 2), results in
protein misfolding and aggregation, in accordance with a general,
although not always unique, toxic gain of function mechanism
of pathogenesis (Williams and Paulson, 2008). The appearance
of insoluble cytoplasmic or nuclear inclusions enriched in the
expanded polyA- or polyQ-containing protein constitutes a char-
acteristic fingerprint of these diseases (Messaed and Rouleau, 2009;
Orr, 2012a), regardless of their controversial role in pathogenesis.
While the proteins containing polyA repeats are predominantly
transcription factors with a role in development (see Table 1
and Amiel et al., 2004; Messaed and Rouleau, 2009), most of
the proteins linked to polyQ-expansion diseases are involved in
DNA-dependent regulation of transcription or neurogenesis and
often contain multiple intermolecular partners (Butland et al.,
2007). Despite the overall lack of sequence or structural homol-
ogy, both polyQ- and polyA-repeat expansions are associated with
formation of ß-rich amyloid-like protein inclusions, and with the
wider group of protein misfolding disorders. These inclusions are
enriched in ubiquitin, proteasome subunits, and chaperones, and
often recruit macromolecules that are part of the macromolecular
interaction networks associated with the proteins’ native functions
(Williams and Paulson, 2008). As an example, the poly(A)-binding
protein PABNP1 forms insoluble inclusions upon alanine expan-
sion, co-aggregating together with poly(A)-mRNA, proteasome
subunits, ubiquitin, heat-shock proteins, and SKIP, a transcrip-
tion factor associated with muscle-specific gene expression (Brais,
2003; Tavanez et al., 2009; Winter et al., 2013).
The simplistic view of the predominant role of the inclusions
in polyQ-induced pathogenesis was later challenged by the failure
of this mechanism to explain the cell-specific vulnerability char-
acteristic for each disease and by the identification of numerous
examples of neuronal toxicity in the absence of visible intracellu-
lar inclusions (Arrasate et al., 2004). Indeed, the inclusions were
shown to be fibrillar and display amyloid-like properties both
in vivo and in vitro (Huang et al., 1998; Bevivino and Loll, 2001;
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Sathasivam et al., 2010) and, in a mechanistic parallel with the
pathogenic mechanisms proposed for “classical” amyloids, many
studies suggested that the insoluble inclusions played a protec-
tive role, sequestering toxic, and misfolded protein conformers
(Arrasate et al., 2004; Rub et al., 2006; Miller et al., 2010). Indeed,
soluble intermediates in the aggregation pathway such as mis-
folded β-sheet rich polyQ protein monomers and oligomers have
latter been identified and proposed to represent the major toxic
species (Kayed et al., 2003; Gales et al., 2005; Nagai et al., 2007;
Miller et al., 2011). Also, in OPMD, the primary toxic species are
proposed to be the soluble variants of the expanded polyA-repeat
protein PABPN1 (Messaed et al., 2007). It is currently accepted that
in polyQ disorders the expanded region plays a role in inducing
the self-assembly of the carrier protein, which engages in patho-
genic interactions and leads to the formation of toxic monomers
or oligomers (Takahashi et al., 2008; Weiss et al., 2008) latter
converted to insoluble intracellular amyloid-like oligomers where
both expanded and “normal” protein are sequestered along with
other macromolecular partners (reviewed in Williams and Paul-
son, 2008; Matos et al., 2011; Costa and Paulson, 2012). As more
biochemical data is gathered, more is understood about the role of
amino acid expansions in modulating the interaction with macro-
molecular partners. As an example, expansion of the polyA tract in
PABPN1 results in increased association with Hsp70 chaperones
and type I arginine methyl transferases (Tavanez et al., 2009). This
indicates that the distinct neuropathological features arising from
this amino acid-repeat expansion might at least partially result
from alterations on the native biological functions and macro-
molecular interactions of the carrier protein, which might vary in
different intracellular environments.
Recent data have shown that expansion of polyA repeats is
frequently associated with loss of normal function altering a mul-
titude of cellular pathways with consequences in cell functionality
(Amiel et al., 2004; Messaed and Rouleau, 2009), although protein
aggregation might also play a dominant role in some of the polyA-
associated disorders (Messaed and Rouleau, 2009; Winter et al.,
2013). Studies with polyQ proteins have shown that pathogene-
sis might result from a subtle imbalance in the association of the
mutant protein with multiple cellular partners and that toxicity
and neuronal death could result from a combination of protein
self-assembly and functional alterations (Friedman et al., 2007; Li
et al., 2007b; Lim et al., 2008; Kratter and Finkbeiner, 2010; Orr,
2012b; Pastore and Temussi, 2012). In fact, neuronal death as a
result of polyQ-expansion seems to resemble that of linker cell in
C. elegans (Pilar and Landmesser, 1976; Chu-Wang and Oppen-
heim, 1978; Blum et al., 2012, 2013) which involves the polyQ
protein pqn-4, pointing for a common mechanism for linker cell
death, and neuronal death in polyQ diseases (Blum et al., 2013).
Polyglutamine diseases constitute a representative and largely
studied group of neurodegenerative disorders where considerable
amounts of data have been collected on the role of expanded
polyQ for disease pathogenesis. However, given the proposed func-
tion of polyQ regions in mediating protein–protein interactions,
which might be modulated by polyQ-expansion (Schaefer et al.,
2012), the information on the role of these regions for native pro-
tein function, structure, and dynamics is still limited. Structural
and functional information on the role of these repeat sequences
in protein function is crucial to better understand how expan-
sion affects selected neuronal subpopulations. Below, we briefly
discuss the current knowledge on the function and structure of
polyQ repeats and their role on macromolecular interactions, and
finally focus on the known structural and functional information
on ataxin-3, the protein whose mutation causes MJD.
FUNCTION OF PolyQ ON PROTEIN–PROTEIN INTERACTIONS
AND EVOLUTION
Until recently, the function of many amino acid-repeat-containing
proteins and the role of homopeptide regions were somewhat
obscure. However, several global analysis studies on single amino
acid-repeat-containing proteins shed light onto their function and
onto the biological significance of the repeated region, in particu-
lar of polyQ, the most prevalent amino acid repetition in humans
(Alba and Guigo, 2004). It is now accepted that TNR, particu-
larly those located within protein-coding regions, are considered
important mutators providing the genetic variability required for
driving evolution (King, 1994; Kashi et al., 1997; Kashi and King,
2006; Nithianantharajah and Hannan, 2007). In fact, simple or
low-complexity amino acid-repeats are rare within prokaryotic
but extremely abundant within eukaryotic proteins, particularly
over-represented in Plasmodium (49–90% of the total proteome),
D. discoideum (52%), D. melanogaster (20%), C. elegans (9%),
and H. sapiens (14%) (Haerty and Golding, 2010). Among all
homopolymeric repeats, the most common on eukaryotic pro-
teins are glutamine, asparagine, alanine, and glutamate repeats
(Faux et al., 2005). This seems to indicate that there has been a
strong negative selection against the appearance of hydrophobic
amino acid-repeats with high tendency to aggregate, such as poly-
isoleucine, polyleucine, polyphenylalanine, and polyvaline (Oma
et al., 2005, 2007).
The homopeptide regions seem to be particularly relevant for
brain development and function, since these repeated regions can
be found in various neurodevelopmental genes (Nithiananthara-
jah and Hannan, 2007). Indeed, the sexual behavior of prairie
voles (Hammock andYoung, 2005), as well as human pair-bonding
(Walum et al., 2008), seems to be dependent on the repeat length
in the vasopressin 1A receptor gene. A wide study of the distribu-
tion and function of homopeptide-containing proteins could also
demonstrate a clear trend in humans, D. melanogater, and C. ele-
gans, with the majority of homopeptide-containing proteins per-
forming roles in transcription/translation and signaling processes
and to a less extend in transport and adhesion processes (Faux
et al., 2005). A similar profile was also found in a comparative
analysis of proteins with amino acid-repeats in human and rodents
(Alba and Guigo, 2004) and also on a comparative genomic study
in domestic dogs, which unveiled an association between mor-
phological variations and the length of the repeated region in the
transcription factor-encoded genes ALX4 and RUNX2 (Fondon
and Garner,2004). Analysis of the human genome also revealed the
existence of 64 CAG repeat-containing genes involved in biological
processes such as regulation of transcription, binding of transcrip-
tional co-activators and transcription factors, and in neurogenesis
in general (Butland et al., 2007). Additionally, a detailed analy-
sis of the human polyQ database (http://pxgrid.med.monash.
edu.au/polyq/) (Robertson et al., 2011) also indicated that the
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majority of polyQ-containing proteins display domains involved
in development (Homeobox domain-containing proteins, Fibrob-
last growth factor receptor), chromatin remodeling (Bromod-
omain and PHD-containing proteins), and signal transduction
(PDZ domain-containing proteins), all biological processes that
are highly dependent on protein–protein interactions and associ-
ated with the formation of multicomponent protein complexes. As
for humans, analysis of bovine polyQ proteins revealed an enrich-
ment for large multi-domain transcriptional regulators (Whan
et al., 2010).
It is currently accepted that the majority of repeat-containing
proteins perform roles in processes that require the assembly of
large multiprotein or protein/nucleic acid complexes (Faux et al.,
2005; Hancock and Simon, 2005; Whan et al., 2010). Supporting
this notion is the fact that homopolymeric amino acid-repeats are
considered to be unstructured (Gojobori and Ueda, 2011) and
that intrinsically unstructured regions are suggested to consti-
tute macromolecular docking sites, which become structured only
when bound to cognate ligand partners (Huntley and Golding,
2002; Simon and Hancock, 2009). In fact, “hub proteins” con-
tain significantly longer and more frequent repeats or disordered
regions, which facilitate binding to multiple partners (Dosztanyi
et al., 2006). Recently, Fiumara et al. (2010) found an overrep-
resentation of coiled-coils domains in polyQ-containing proteins
and in their interaction partners, which are able to form α-helical
supersecondary structures, often inducing protein oligomeriza-
tion (Parry et al., 2008). Thus, polyQ tracts due to their intrinsic
structural flexibility, which is largely influenced by the flanking
residues (see PolyQ:A Simple Sequence Repeat with a Polymorphic
Structure below), may act as stabilizers of intra- and intermole-
cular protein interactions, possibly by extending a neighboring
coiled-coil region to promote its interaction with a coiled-coil
region in an interacting protein partner (Schaefer et al., 2012).
A detailed analysis revealed heptad repeats typical of coiled-coils
in regions flanking or overlapping polyQ stretches, whose disrup-
tion is sufficient to impair CHIP-huntingtin interaction, indicating
that coiled-coils are crucial for polyQ-mediated protein contacts.
Importantly, coiled-coils also seem to be important for the regula-
tion of aggregation and insolubility of polyQ-containing proteins
(see below and Fiumara et al., 2010) as recently proposed by
Petrakis et al. (2012), which discovered a recurrent presence of
coiled-coil domains in ataxin-1 misfolding enhancers, while such
domains were not present in suppressors.
Based on the several observations on the function of polyQ-
containing proteins it is suggested that a general function of polyQ,
as for the majority of repeat sequences, is to aid in the assem-
bly of macromolecular complexes, either through tethered distant
domains or through interactions with the polyQ itself (Gerber
et al., 1994; Korschen et al., 1999; Faux et al., 2005). By affecting
protein interactions, and being present in particular functional
classes such as transcription factors, polyQ is considered central to
the evolution of this type of proteins and consequently crucial to
the evolution of cellular signaling pathways (Hancock and Simon,
2005).
A structural analysis of polyQ repeats and its flanking domains
as well as its role in protein aggregation will be discussed in greater
detail in the next sections.
STRUCTURAL STUDIES ON PolyQ REPEATS
Since the discovery that polyQ repeats are associated with human
neurodegenerative diseases that a huge effort has been made to
determine the structure of polyQ and to understand how expan-
sion of the repeat affects the structure of the carrier protein and/or
the normal interaction with molecular partners. The first evidence
from the aggregation-prone character of polyQ-rich proteins came
from studies with glutamine-rich cereal storage proteins and syn-
thetic glutamine polypeptides (Beckwith et al., 1965; Krull et al.,
1965). After the discovery that a number of neurological disor-
ders were triggered by expansion of a polyQ tract in different and
unrelated proteins (La Spada et al., 1994), and before intracellular
inclusions enriched in the polyQ-expanded protein were identi-
fied as a major fingerprint in these diseases (Davies et al., 1997;
Paulson et al., 1997), Perutz (1994) anticipated that the expanded
polyQ tract could mediate protein–protein interactions causing
protein aggregation in neurons and recruiting other polyQ-rich
proteins such as transcription factors leading to cellular dysfunc-
tion. Below, the structural features and self-assembly properties of
polyQ sequences are briefly discussed (for a detailed review on the
biophysical and structural features of polyQ, see Wetzel, 2012).
PolyQ: A SIMPLE SEQUENCE REPEAT WITH A POLYMORPHIC
STRUCTURE
In order to elucidate the structure of the glutamine repeat and
to uncover the structural changes induced by polyQ expansion,
several strategies have been put forward including (a) the struc-
tural analysis of polyQ-containing peptides of different lengths,
(b) the characterization of proteins of well-known structure after
insertion of an exogenous polyQ repeat, and structural determina-
tion of (c) polyQ-antibody complexes, or (d) natural polyQ-rich
proteins.
Using synthetic peptides containing 15 glutamine repeats,
Perutz and coworkers proposed that polyQ stretches could self-
associate forming hydrogen bonds between their side-chain amide
groups and the main chain of a neighboring β-strand, to form
cross-β structures (polar zippers) (Perutz, 1994). This study was
followed by many reports where synthetic polyQ peptides were
used as models of the biophysical properties of polyQ-rich pro-
teins, which established that polyQ-containing peptides have a
tendency toward self-assembly into amyloid-like structures (Chen
et al., 2002a). Moreover, the results obtained in vitro reflected dis-
ease features observed in vivo such as the correlation between
larger polyQ size, increased protein aggregation, and earlier disease
onset (Chen et al., 2002b; Kar et al., 2011). Circular dichroism stud-
ies of polyQ peptides in solution have shown that their monomeric
forms lack regular secondary structure (Altschuler et al., 1997;
Klein et al., 2007) and additional biophysical experiments pro-
posed that these peptides can adopt collapsed (Crick et al., 2006;
Dougan et al., 2009; Peters-Libeu et al., 2012) or extended (Singh
and Lapidus, 2008) coils in solution whose compactness was
strongly correlated with the polyQ size (Walters and Murphy,
2009). The determination of the structure of monomeric polyQ
peptides with atomic detail is however still lacking as a result of
their intrinsic conformational flexibility and tendency to aggregate
into heterogeneously sized β-rich oligomers. From the combina-
tion of experimental and theoretical methods a picture for polyQ
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structure and aggregation is emerging, where the monomeric
polyQ adopt an ensemble of conformations lacking regular sec-
ondary structures that assemble into β-structures in a polyQ-
length dependent fashion (Vitalis et al., 2009; Walters and Murphy,
2009, 2011; Williamson et al., 2010; Kar et al., 2011). Divergent
results proposing the existence of predominantly extended or col-
lapsed conformations or the minimum size for polyQ aggregation
are likely due to the differences in the introduction of variable
flanking residues (Kar et al., 2011). They might result from the
insertion of different polyQ tract interrupting residues (Walters
and Murphy, 2011), or be a consequence of the protocols used for
the preparation and disaggregation of the peptides used for the
biophysical studies (Jayaraman et al., 2011). Most results obtained
with these peptides do not generally take into account the pos-
sible effects of the protein context on the structural properties
of the polyQ stretches, a particularly relevant feature considering
that the role of non-polyQ domains in protein aggregation has
been reported for ataxin-1 (de Chiara et al., 2005), ataxin-3 (Gales
et al., 2005), and huntingtin (Tam et al., 2009; Thakur et al., 2009;
Liebman and Meredith, 2010).
In a pioneer work, Stott et al. (1995) inserted a G-Q10-
G peptide into the inhibitory loop of chymotrypsin inhibitor
2 (CI2), a soluble small protein from barley seeds, showing
that this CI2-polyQ chimera has an increased tendency for self-
assembly. Even though a CI2 variant with four glutamines crys-
tallized, the structure of the CI2-Q4 dimer showed that the
polyQ region was disordered and that oligomerization was medi-
ated by domain swapping (Figure 3A) and not by direct polyQ
association (Chen et al., 1999). A structure resembling the pro-
posed polar zipper was later observed between two asparagines
in the hinge loop of the major domain swapped dimer of
bovine pancreatic ribonuclease A (Liu et al., 2001) (Figure 3B).
Insertion of a 10 glutamine repeat within this hinge loop of
ribonuclease A, resulted in domain swapping, oligomerization,
and amyloid-like fiber formation, but strikingly the enzyme
within the fibers was catalytically active, retaining its native
fold (Sambashivan et al., 2005). However, although the struc-
ture of the domain swapped dimer was solved by X-ray crys-
tallography, the repeat region was not visible in the electron
density maps.
FIGURE 3 | Structure of proteins/protein domains containing polyQ
regions. (A) Cartoon representation of the domain swapped dimer of
chymotrypsin inhibitor 2 with a 4 glutamine insertion [(Chen et al., 1999); PDB
accession code 1cq4], dotted lines represent the polyQ linker not visible in
the X-ray crystal structure. (B) Cartoon representation of domain swapped
major dimers of ribonuclease A. Inset shows a short segment resembling the
polar zipper formed by asparagine residues in the linker region [(Liu et al.,
2001); PDB accession code 1f0v]. (C) Surface representation Fv fragment of a
monoclonal antibody in complex with a polyQ peptide shown as sticks [(Li
et al., 2007a), PDB accession code 2otu]. (D) Cartoon representation of the
glutamine-rich domain from HDAC4 showing details of the polar interactions
(dotted lines) at the oligomer interfaces involving glutamine residues [(Guo
et al., 2007), PDB accession code 2o94]. (E) Cartoon representation of the
crystal structures of huntingtin exon-1 fragments observed in different crystal
forms, highlighting the different orientations of the C-terminal polyQ residues
shown as sticks. The 17 glutamine stretch adopts variable conformations in
the structures: α helix, random coil, and extended loop. [(Kim et al., 2009),
PDB accession codes 3io4, 3iow, 3iov, 3iou, 3iot, 3ior, 3io6].
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A first overview of a short polyQ stretch at atomic resolu-
tion resulted from the structure of a polyQ10 peptide (GQ10G)
(Figure 3C) bound to MW1, an antibody against polyQ. This
structure reveals that polyQ adopts an extended, coil-like struc-
ture in which contacts are made between side chains and/or main
chain atoms of all 10 glutamines and the antibody-combining site
(Li et al., 2007a). The peculiar structural features of these repeat-
containing regions were also revealed by the crystallographic
structure of a glutamine-rich domain of human histone deacety-
lase (HDAC4), that folds into a tetramer-forming straight α-helix
(Figure 3D). The protein interfaces consist of multiple hydropho-
bic patches separated by polar interaction networks, in which
clusters of glutamines engage in extensive intra- and interheli-
cal interactions (Guo et al., 2007). Further details on the structure
of polyQ were unveiled by the high-resolution crystal structures
of huntingtin (HD) exon 1, containing 17 glutamines (Htt17Q)
(Kim et al., 2009). Htt17Q in fusion with maltose-binding pro-
tein (MBP) folds into an amino-terminal α-helix followed by a
polyQ17 region that adopts multiple conformations in the differ-
ent crystal forms, including α-helix, random coil, and extended
loop, and a polyproline helix formed by the polyP11 and mixed
P/Q regions (Figure 3E). The authors suggested that the shallow
equilibrium between α-helical, random coil, and extended confor-
mations can be subtly altered by the size of polyQ sequence, the
neighboring protein context, protein interactions, or by changes
in cellular environment, and that this polymorphic behavior is
a common characteristic of many amyloidogenic proteins (Kim
et al., 2009).
SELF-ASSEMBLY AND AGGREGATION OF PolyQ REPEATS
The first approaches to characterize polyQ-induced protein aggre-
gation and pathogenesis in the context of a full-length protein
included the insertion of the polyQ peptides into well-known non-
pathogenic protein carriers such as hypoxanthinephosphoribosyl
transferase (HPRT), which resulted in a neurological phenotype
mimicking that observed in mice expressing the mutant HD trun-
cated protein (Ordway et al., 1997). In vitro studies aiming at better
characterizing the structure and function of polyQ repeats in the
context of full-length soluble proteins, included the insertion of
ectopic polyQ stretches into well-characterized and soluble pro-
teins such as CI2 (Stott et al., 1995; Chen et al., 1999), myoglobin
(Mb) (Tanaka et al., 2001; Tobelmann and Murphy, 2011), glu-
tathione S transferase (GST) (Masino et al., 2002; Bulone et al.,
2006) and the B domain from Staphylococcus aureus Protein A
(SpA) (Saunders et al., 2011). Fusion of the polyQ sequences
with stable and soluble proteins moderates the intrinsic polyQ
peptide aggregation propensity, but induces the self-assembly of
carrier proteins into fibrillar amyloid-like structures, a nucleation-
dependent process whose kinetics is directly proportional to the
size of the inserted polyQ repeat. Likewise, polyQ peptides are able
to seed the aggregation of intracellular soluble polyQ-containing
proteins when added to cell cultures, conferring a heritable pheno-
type of self-sustaining seeding, resembling a prion-like mechanism
(Ren et al., 2009), reviewed in Cushman et al. (2010).
The impact of the polyQ tract and its expansion on the per-
turbation of the structure of flanking sequences and domains is
critically dependent on the location of the amino acid-repeats,
revealing impressive location-dependent changes in structural sta-
bility, and fibril morphology of the host proteins (Robertson
et al., 2008; Saunders et al., 2011; Tobelmann and Murphy, 2011).
Curiously, the studies with these model proteins showed that sta-
bility and structure of the carrier protein remained unaltered
by polyQ expansion when the repeat was inserted at the N- or
C-terminus of the structured domain (Robertson et al., 2008),
mimicking the location of polyQ tracts in most disease-related
proteins (Figure 1).
The role of the flanking regions in modulating protein fibril
formation in polyQ disease proteins is well supported by experi-
mental data (de Chiara et al., 2005; Gales et al., 2005; Bhattacharyya
et al., 2006; Saunders and Bottomley,2009; Tam et al., 2009; Thakur
et al., 2009; Liebman and Meredith, 2010), in agreement with the
knowledge that different polyQ-containing proteins have a diverse
threshold for aggregation. For example, addition of a polyproline
extension after the polyQ repeat slows down aggregation (Bhat-
tacharyya et al., 2006), while protein domains outside the polyQ
tract [e.g., Josephin domain (JD) of ataxin-3 and AHX domain
of ataxin-1] have been shown to contribute to protein aggre-
gation (Masino et al., 2004; de Chiara et al., 2005; Gales et al.,
2005; Ellisdon et al., 2006, 2007). The multitude of data on the
polyQ-induced aggregation of disease and non-disease-proteins
highlights the complex interplay between the polyQ region and
the adjacent protein domains. In light of the polymorphic nature
of the polyQ and the modulation of its structural features by
the protein context, two general mechanisms have been proposed
for polyQ-mediated toxicity (Kim et al., 2009): (a) the expanded
polyQ stretch adopts a novel conformation that mediates toxicity
or is the precursor to toxic species; (b) intra- or intermolecular
protein interactions mediated by expanded polyQ in the random
coil conformation are sufficient to result in pathological effects. In
both cases the affinity of the interactions involving the expanded
polyQ region could be higher with selected target proteins, lead-
ing to a preference of the disease proteins for some of the protein
partners, a fact that is in agreement with the hypothesis raised
by Zuchner and Brundin (2008), which postulate that resistance
to NMDA receptor-mediated excitotoxicity occurring in some
mouse models for HD is a consequence of a differential bind-
ing of partner proteins, in a polyQ tract size dependent manner, to
the proline-rich domain of huntingtin. In this context, differences
in molecular interactions occurring in a cell- and tissue-specific
manner would result in different toxicities according to particular
cellular environments.
Given the above mentioned studies, it is nowadays clear that the
polyQ region influences aggregation of proteins, but this process is
highly dependent on the surrounding protein context. Therefore,
even though the structural information on peptides and proteins
with polyQ expansions is a useful guideline for the investiga-
tion of the pathogenic effects of polyQ expansion, each of the
proteins involved in polyQ diseases shows distinctive characteris-
tics, cellular roles, and structural properties causing difficulties in
the formulation of structural hypothesis that could explain how
different monomeric conformations of polyQ leads to various
aggregated species and how they contribute to neurotoxicity.
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PolyQ REPEATS IN ATAXIN-3 FUNCTION AND DYSFUNCTION
Machado-Joseph disease is an inherited neurodegenerative disor-
der of adult onset originally described in people of Portuguese
Azorean descent but later shown to be the most common auto-
somal dominant spinocerebellar ataxia worldwide. Clinically, it is
characterized by ataxia, ophthalmoplegia, and pyramidal signs,
associated in variable degree with dystonia, spasticity, periph-
eral neuropathy, and amyotrophy (Coutinho and Andrade, 1978).
Pathologically, the disorder is associated with degeneration of
the deep nuclei of the cerebellum, pontine nuclei, subthalamic
nuclei, substantia nigra, and spinocerebellar nuclei (Coutinho
et al., 1982; Rosenberg, 1992; Margolis and Ross, 2001). It is caused
by an expansion of a repetitive CAG tract within the ATXN3 gene
(Kawaguchi et al., 1994). While in the healthy population the num-
ber of CAG repeats ranges between 10 and 51, in MJD patients the
length of ataxin-3 polyQ tract exceeds 55 consecutive residues.
Ataxin-3 is a modular protein, located both in the nucleus and the
cytoplasm (Perez et al., 1999; Antony et al., 2009; Macedo-Ribeiro
et al., 2009), encompassing an N-terminal globular JD, with struc-
tural similarity to cysteine proteases (Scheel et al., 2003; Albrecht
et al., 2004), followed by an extended tail composed of two ubiq-
uitin interaction motifs (UIMs), the expandable polyQ tract, and
a C-terminal region (Matos et al., 2011). The C-terminal region of
ataxin-3 may contain a third UIM, depending on the splice vari-
ant (Goto et al., 1997), with the 3UIM isoform of ataxin-3 being
predominantly found in the brain (Harris et al., 2010). Currently,
the physiological function of ataxin-3, as well as the molecular
mechanism by which expanded polyQ sequences causes selective
neurodegeneration remain mostly unknown. However, since it
is ubiquitously expressed and cell death is region specific, neu-
rodegeneration is currently viewed as depending on sequence and
structural features outside the ataxin-3 polyQ tract [reviewed in
Matos et al. (2011) and references therein].
ATAXIN-3 BIOLOGICAL ROLES
ATXN3 orthologs have been identified in eukaryotic organisms
including protozoans, plants, fungi, and animals (Albrecht et al.,
2004; Costa et al., 2004; Rodrigues et al., 2007). Several functions
have been ascertained to ataxin-3 based on studies with orthologs.
Specifically, a role in cell structure and/or motility was proposed
for mouse ataxin-3 as it is highly abundant in all types of muscle
and in ciliated epithelial cells (Costa et al., 2004). In fact, ataxin-3
is able to interact with tubulin through its JD domain (Figure 4),
with nM affinity (Mazzucchelli et al., 2009), which supports a
role in cell structure. Interestingly, data on ataxin-3 C. elegans
ortholog not only reinforces a function in structure/motility and
signal transduction (Rodrigues et al., 2007), but also indicate a
function in development as absence of ATXN3 strongly modifies
expression of several development-related genes. ATXN3 knock-
out animals showed no obvious deleterious phenotype, probably
due to a putative redundant function between ataxin-3 and other
JD-encoding proteins, such as ataxin-3-like protein, Josephin 1 and
Josephin 2, all containing a typical cysteine protease catalytic triad.
However the studies with ATXN3 knock-out animals revealed an
overall increase in the levels of ubiquitinated proteins (Schmitt
et al., 2007) and signs of altered expression of core sets of genes
associated with the ubiquitin-proteasome and signal transduction
pathways (Rodrigues et al., 2007), pointing to a dual function of
ataxin-3 in the ubiquitin-proteasome system and transcriptional
regulation (Matos et al., 2011; Orr, 2012a).
Ataxin-3 function as transcriptional regulator
The putative role of ataxin-3 in transcriptional regulation is
proposed to entail the modulation of histone acetylation and
deacetylation at selected promoters. Ataxin-3 interacts with the
major histone acetyltransferases cAMP-response-element binding
protein (CREB)-binding protein (CBP), p300, and p300/CREB-
binding protein-associated factor (KAT2B/PCAF, Figures 4 and
5), and is proposed to inhibit transcription in specific promot-
ers (e.g., MMP-2 promoter) either by blocking access to histone
acetylation sites or through recruitment of histone deacetylase 3
(HDAC3) and nuclear receptor co-repressor (NCOR1; Figures 4
and 5) (Li et al., 2002; Evert et al., 2006). Although, the interac-
tion sites have not been mapped in detail for all these proteins,
co-immunoprecipitation experiments showed that KAT2B/PCAF,
p300, and CBP bind exclusively to the polyQ-containing C-
terminal region of ataxin-3 (Figure 4), apparently in a polyQ-size
dependent manner (Li et al., 2002). Experimental evidence also
indicates that ataxin-3 forms part of a CREB-containing complex,
although no direct interaction has been observed between the two
proteins (Li et al., 2002). In contrast, the N-terminal region of
ataxin-3 directly binds histones H3 and H4 (Table 2; Figure 4)
(Li et al., 2002). Of note, p300 and CBP, as well as NCOR1,
also encompass amino acid repetitions in its sequence. Interest-
ingly, in huntingtin and in ataxin-1, polyQ interferes with CBP-
activated gene transcription via interaction of their glutamine-
rich domains (Shimohata et al., 2000; Nucifora et al., 2001) and
mutant huntingtin targets specific components of the core tran-
scriptional machinery, in a glutamine-tract length-sensitive man-
ner (Zhai et al., 2005), pinpointing once again the role of the
amino acid-repeat region in the establishment of protein–protein
interactions.
Ataxin-3 molecular function: ubiquitin hydrolase
A role for ataxin-3 in ubiquitin-dependent pathways was pro-
posed by bioinformatic analysis (Scheel et al., 2003; Albrecht et al.,
2004), and its ability to bind and cleave poly-ubiquitin chains
and polyubiquitinated proteins was later demonstrated experi-
mentally (Burnett et al., 2003; Chai et al., 2004). Importantly,
inhibition of ataxin-3 catalytic activity results in the increase
of polyubiquitinated proteins, resembling the effects of protea-
some inhibition (Berke et al., 2005), indicating that ataxin-3 is
involved with proteins targeted for proteasomal degradation. The
function of ataxin-3 in the ubiquitin-proteasome system was fur-
ther supported by the identification of its association with the
ubiquitin-like domain of the human homologs of the yeast DNA
repair protein Rad23, HHR23A, and HHR23B (Wang et al., 2000;
Doss-Pepe et al., 2003; Nicastro et al., 2005, 2009), with valosin-
containing protein (VCP)/p97 (Hirabayashi et al., 2001; Doss-Pepe
et al., 2003; Boeddrich et al., 2006; Zhong and Pittman, 2006), and
with the ubiquitin ligase E4B (Matsumoto et al., 2004) (Figures 4
and 5). Strikingly, the weak direct association between ataxin-3
and E4B is strongly reinforced by the addition of VCP/p97, indicat-
ing that these proteins form part of a higher order macromolecular
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FIGURE 4 | Overview of ataxin-3 structural information. Schematic
illustration of ataxin-3 (isoform 2; a.k.a. 3UIM isoform) domain structure
highlighting the regions involved in protein–protein interactions. The solution
structures of the Josephin domain (PDB accession code 1yzb) and UIMs1-2
(PDB accession code 2klz) are shown colored from N-(blue) to C- terminus
(red). JD-, UIM-, NLS-, and polyQ-mediated interactions are represented by
blue, red, green, and purple arrows, respectively; blue arrows indicate the
location of post-translational modification sites, resulting from the interaction
and phosphorylation by CK2 and GSK3. Representative multi-subunit
complexes where ataxin-3 participates are boxed (Li et al., 2002; Matsumoto
et al., 2004; Scaglione et al., 2011; Durcan et al., 2012). One of the main
questions in the quest for ataxin-3 interacting proteins is whether
polyQ-expansion of the disease-protein modulates the binding affinities.
Current data indicates that polyQ-expansion increments the ataxin-3 affinity
for CHIP (Scaglione et al., 2011), VCP/p97 (Matsumoto et al., 2004; Boeddrich
et al., 2006; Zhong and Pittman, 2006), and the transcription regulators p300,
CBP, and PCAF (Li et al., 2002) (interactions represented by broken lines).
Strikingly, all these interactions are mediated by ataxin-3 flexible tail, which
includes the polyQ tract. Moreover the transcriptional regulators p300, CBP,
and NCOR all contain amino acid repeats.
complex to regulate the degradation of misfolded ER proteins
(Matsumoto et al., 2004; Zhong and Pittman, 2006) (Figure 5).
Biochemical studies showed that ataxin-3 displays a strong
preference for chains containing four or more ubiquitins (Chai
et al., 2004) and that full-length ataxin-3 and its JD both display
proteolytic activity toward either linear substrates containing a
single ubiquitin molecule (Burnett et al., 2003; Chow et al., 2004b;
Weeks et al., 2011) or K48/K63-linked poly-ubiquitin chains (Win-
born et al., 2008; Todi et al., 2009), displaying also the capacity to
bind the ubiquitin-like protein NEED8 in a substrate-like fashion
(Ferro et al., 2007). Moreover, ataxin-3-like protein, Josephin 1 and
Josephin 2, also display ubiquitin protease activity (Tzvetkov and
Breuer, 2007; Weeks et al., 2011), although the relative activities are
highly variable in spite of their high sequence similarity. Charac-
terization of ataxin-3 ubiquitin hydrolase activity has also revealed
that the full-length protein preferentially cleaves Lys-63-linked
and mixed-linkage chains with more than four ubiquitins (Bur-
nett et al., 2003; Winborn et al., 2008). This specificity is dictated
by the UIMs, as the isolated JD shows a preference toward the
disassembly of Lys-48-linked chains (Nicastro et al., 2009, 2010).
Altogether, this indicates that ataxin-3 ubiquitin hydrolase activ-
ity is likely to be associated with delivery of target substrates to
the proteasome rather than with their rescue from degradation,
as it happens with most of the other deubiquitinases (Ventii and
Wilkinson, 2008; Matos et al., 2011; Scaglione et al., 2011). Inter-
estingly, ubiquitin hydrolase activity of ataxin-3 is not affected
by polyQ expansion and both normal and expanded ataxin-3 are
able to increase the cellular levels of a short-lived GFP normally
degraded by the ubiquitin-proteasome pathway (Burnett et al.,
2003).
The 3D structures for JD alone or in the presence of ubiquitin as
well as that of the tandem UIM1-UIM2 have already been deter-
mined (Mao et al., 2005; Nicastro et al., 2005, 2009; Song et al.,
2010), giving a structural perspective on the ubiquitin hydrolase
function of ataxin-3. The JD contains two ubiquitin binding sites,
both of hydrophobic nature, with site 1 being negatively charged to
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FIGURE 5 | Overview of ataxin-3 protein interaction network. Data on
the ataxin-3 interactors was obtained by analysis of Interactome3D (Mosca
et al., 2012), MINT (Ceol et al., 2010), and Dr. PIAS (Sugaya and Furuya,
2011) protein interaction databases, and completed with data compiled
from current literature on ataxin-3 protein associations obtained with a
diverse set of experimental approaches (see complete information on
Table 2). Red arrows indicate interactions for which structural data has been
obtained, while orange arrows indicate that biophysical data on interaction
affinity in vitro is known (Table 2). Broken arrows represent interactions that
result from high-throughput interactome analysis that still require detailed
biochemical and functional analysis. Proteins are grouped according to their
biological role.
facilitate docking of the positively charged ubiquitin C-terminus
close to the catalytic site. Binding of ubiquitin to site 1 is of crucial
importance for both JD and full-length ataxin-3 activity as ubiqui-
tin hydrolase (Nicastro et al., 2010). Site 2 confers ubiquitin-chain
linkage preference to ataxin-3 and it overlaps with the surface for
interaction of the ubiquitin-like domain in HHR23B (Nicastro
et al., 2005, 2010). Solution structure for the two UIMs (UIM1
and UIM2), which are separated by a short 2 amino acid spacer,
revealed that they fold into two α-helices separated by a flexible
linker (Song et al., 2010). Upon ubiquitin binding, this structure
adopts a typical helix-loop-helix folding pattern, where hydropho-
bic interactions dominate the complex formation (Song et al.,
2010). When in tandem, UIM1 and UIM2 show higher binding
affinity for mono- or poly-ubiquitin than individual UIMs (Song
et al., 2010), suggesting a cooperative binding mechanism (Song
et al., 2010). The effect of the presence of UIM3 in ataxin-3 binding
affinity for ubiquitin has not been shown, but its role in ubiqui-
tin chain binding and recognition is unlikely to be of relevance to
ataxin-3 activity, since no differences in proteolytic activity were
identified when the 2UIM and 3UIM isoforms were compared. In
the model proposed for ataxin-3 ubiquitin chain proteolysis, the
UIMs (UIM1-UIM2) select and recruit poly-ubiquitin substrates,
presenting them to the catalytic JD for cleavage (Mao et al., 2005).
Even though ataxin-3 functions as ubiquitin hydrolase, its pro-
teolytic activity is rather low, indicating that either ataxin-3/JD
requires additional factors (post-translational modifications,
cofactors, intracellular interactions) to exhibit significant prote-
olytic activity or the substrates used in vitro so far are not optimal.
Interestingly, only three amino acid mutations are sufficient to
significantly increase the proteolytic activity of ataxin-3, to a
value close to that of ataxin-3-like protein (Weeks et al., 2011).
Under physiological conditions, one candidate for an activating
signal is mono-ubiquitination at K117, which has been shown
to increase the enzyme’s rate of cleavage of Lys-63 linked sub-
strates (Todi et al., 2009). However, the molecular mechanism by
which ubiquitination increases enzyme activity is not still clear,
nor is it known whether other cellular signals (e.g., phospho-
rylation by CK2 or GSK3b; Fei et al., 2007; Tao et al., 2008)
may also modulate the activity of ataxin-3. Interestingly the JD-
containing protein, Josephin 1 was also demonstrated to cleave
ubiquitin chains only after it is mono-ubiquitinated (Seki et al.,
2013). The regulation of ataxin-3 activity through ubiquitination
might depend on the interaction of ataxin-3 with several E3 ubiq-
uitin ligases (Durcan and Fon, 2013), such as the C-terminus of
70 kDa heat-shock protein (Hsp70)-interacting protein (CHIP),
parkin, and E4B (Figure 5), since all were shown to promote
ataxin-3 ubiquitination and regulate its degradation by the pro-
teasome (Matsumoto et al., 2004; Jana et al., 2005; Miller et al.,
2005). Association of ataxin-3 with CHIP is a multistep process
regulated by mono-ubiquitination of the N-terminal region of
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CHIP by the E2-conjugating enzyme Ube2w, and occurs through
the region encompassing polyQ and UIM1 and 2 (Jana et al.,
2005) (Figure 4). As observed for other interactions involving
the C-terminal region of ataxin-3, the ataxin-3-CHIP complex is
affected by polyQ expansion and the polyQ-expanded protein dis-
plays a sixfold increase in binding affinity (Scaglione et al., 2011).
The presence of ataxin-3 in multicomponent E3-ligase complexes
is also supported by the identification of a direct interaction
with parkin, an association that stabilizes the interaction between
parkin and the E2-conjugating enzyme Ubc7 (Durcan et al., 2011).
In contrast with what is observed in the ataxin-3:CHIP com-
plex, ataxin-3 association with parkin remains unaltered by polyQ
expansion (Durcan et al., 2012) (Figure 4). However, we still do
not understand the mechanisms that regulate shuttling of ataxin-
3 between these functional complexes or how its distribution is
modulated by polyQ expansion. Further biochemical studies are
required to establish the correlation between these macromolec-
ular interactions and their relevance for ataxin-3 aggregation and
neurodegeneration in MJD patients
ATAXIN-3 AGGREGATION: A MULTISTEP PATHWAY MODULATED BY
THE PROTEIN CONTEXT
A characteristic hallmark of MJD and other polyQ-expansion dis-
eases is the appearance of intracellular inclusions enriched in
the disease protein and containing components from the cell-
quality control machinery (e.g., ubiquitin, proteasome subunits,
and chaperones), indicating that these diseases form part of the
larger family of protein misfolding disorders (Williams and Paul-
son, 2008). Early in vitro studies showed that expansion of the
polyQ tract within the pathological range induced formation
of insoluble β-rich fibrils with the capacity to bind amyloid-
specific dyes (Bevivino and Loll, 2001). Later it was demonstrated
that non-pathological ataxin-3 could also form insoluble fibrillar
aggregates upon destabilization of its structure by temperature,
pressure or denaturing agents (Marchal et al., 2003; Chow et al.,
2004c). Unexpectedly, under partially destabilizing conditions the
JD was also able to form insoluble fibrils, indicating that even
though polyQ repeats are themselves toxic, the structure of ataxin-
3, besides polyQ, has an important role in aggregation and fibril
formation (Masino et al., 2004). Structural studies have shown
that in ataxin-3, the addition of a polyQ tract destabilized the
protein but polyQ expansion within the pathogenic range did
not further induce significant structural changes (Chow et al.,
2004a). In fact, alterations in ataxin-3 stability were later shown
not to be a requirement for amyloid fibril formation since both
non-expanded ataxin-3 and the isolated JD were shown to self-
assemble and form fibrils under near-physiological conditions
(Gales et al., 2005). Since kinetics of aggregation is slower for
non-expanded ataxin-3 (Ellisdon et al., 2007), early events in the
oligomerization pathway could be identified, with the formation
of JD-mediated dimers proposed to be the first step in the ataxin-3
self-assembly pathway (Gales et al., 2005; Masino et al., 2011; Scarff
et al., 2012). In a striking parallel with the classical amyloids the
kinetics of fibril formation follows a nucleation-dependent poly-
merization mechanism, where these intermediate species might
represent the most toxic species (Kayed et al., 2003; Laganowsky
et al., 2012).
The current model for polyQ-expanded ataxin-3 aggregation
consists of two steps. A JD-dependent step that leads to the for-
mation of SDS-soluble protofibrils, followed by the formation of
detergent-resistant fibrils similar to those found in MJD, where the
polyQ-expanded tracts play a key role (Ellisdon et al., 2006, 2007).
On the contrary, non-expanded polyQ ataxin-3 undergoes a single
step aggregation event resulting in SDS-soluble aggregates, which
does not involve the polyQ tract (Ellisdon et al., 2006) but directly
depends on conformational changes outside the polyQ repeat. In
the initial stages of aggregation, JD retains a native-like secondary
structure, but is deployed of catalytic activity pointing to a subtle
conformational change before fibril assembly (Masino et al., 2011).
Although the JD plays a central role in this aggregation process,
recent studies show that the ataxin-3 flexible region (Masino et al.,
2003; Scarff et al., 2012), encompassing UIM1, and UIM2 also con-
tributes to aggregation of the full-length protein (Santambrogio
et al., 2012). This multistep aggregation modulated by the polyQ
protein context seems to be common in other polyQ disorders such
as HD (Thakur et al., 2009) and SCA1 (de Chiara et al., 2005).
The presence of an expanded polyQ tract leads subsequently to
rapid inter-fibril association and formation of large, highly stable
amyloid-like fibrils. This indicates that the non-polyQ domains
predispose ataxin-3 for aggregation and that the presence of a
pathological polyQ tract introduces an additional step resulting in
the formation of a highly stable amyloid-like aggregate.
This complex aggregation mechanism, involving domains
outside the amino acid-repeat region, is also found in
PABPN1(Tavanez et al., 2005; Winter et al., 2013), a multi-domain
polyA-containing protein consisting of an N-terminal segment
containing the alanine repeat, a coiled-coil domain, a RNA recog-
nition motif (RRM), and a C-terminal domain. As observed for
ataxin-3, the propensity of PABPN1 to aggregate and form amy-
loid fibrils (Scheuermann et al., 2003) is not exclusive of the
expanded protein and can also be observed in the non-disease
protein (Tavanez et al., 2005; Rohrberg et al., 2008). This indicates
that polyA-flanking regions/domains influence the aggregation
process, and that this is likely a broader mechanism common
in homopeptide repeat-containing proteins. In fact, analysis of
PABPN1 sequence indicates higher scores for aggregation propen-
sity within the RRM domain (Tavanez et al., 2009), with muta-
tions in the RRM being sufficient to prevent aggregate formation
(Tavanez et al., 2005).
Aggregation of homopeptide repeat-containing proteins is
therefore a multiparametric process that culminates in cell-specific
degeneration, whose toxicity might be explained by the context-
dependent molecular interactions and post-translational modifi-
cations. The relation between protein interactions, function, and
aggregation will be discussed below, with a particular focus on the
polyQ-containing protein, ataxin-3.
ATAXIN-3 FUNCTION VS. AGGREGATION
Several studies have been focused on the search for specific ataxin-
3 interactors, some of which have identified direct physical associa-
tion between the protein partners and provided clues into ataxin-3
biological role (Table 2 and references herein; Figure 5). Recently,
different high throughput interactome screens focused on the
search for protein complexes associated with ubiquitin hydrolases
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(Sowa et al., 2009), ataxia-related proteins (Lim et al., 2006), signal
transduction pathways (Vinayagam et al., 2011), and transcrip-
tional regulation (Ravasi et al., 2010), contributing with data on
novel putative ataxin-3 binding proteins (Table 2; Figures 4 and 5).
An overview of the current data on the ataxin-3 interactome
shows that a large number of interactions map to the catalytic
JD. The intrinsic tendency of JD to self-associate involves the
hydrophobic patches on its surface, which overlap with the func-
tionally relevant ubiquitin binding sites 1 and 2 (Matos et al.,
2011; Pastore and Temussi, 2012), providing a direct link between
protein function and aggregation and exposing a role for intracel-
lular interactors, such as ubiquitin, in protecting against ataxin-
3 self-assembly (Gales et al., 2005; Masino et al., 2011; Matos
et al., 2011; Pastore and Temussi, 2012). Likewise, in the polyA-
containing protein PABPN1 the RRM domain responsible for
the interaction with the mRNA (Banerjee et al., 2013) and with
polyadenylate-specific RNA polymerase is also involved in the
aggregation process (Winter et al., 2013). In addition, the fact that
heat-shock proteins including Hsp70, and type I arginine methyl
transferases (PRMT1 and PRMT3) associate preferentially with
expanded PABPN1 raises the question whereas proteotoxicity of
expanded PABPN1 might also be caused by altered protein net-
working. Destabilization of the ataxin-3 JD by specific mutations
revealed that any conformational change in this region is directly
linked with aggregation of the full-length protein (Saunders et al.,
2011), emphasizing the putative therapeutical potential associ-
ated with the identification of macro-molecules with the ability
to stabilize this N-terminal region. In fact, interaction of JD with
protein partners (Masino et al., 2011) or chaperones (Robertson
et al., 2010) is sufficient to induce stabilization of JD leading to
a reduction in ataxin-3 self-assembling properties (Matos et al.,
2011; Pastore and Temussi, 2012).
Concerning the C-terminal flexible tail of ataxin-3, the interac-
tion with VCP/p97 is probably the one for which more experimen-
tal data is available (Hirabayashi et al., 2001; Doss-Pepe et al., 2003;
Matsumoto et al., 2004; Boeddrich et al., 2006; Zhong and Pittman,
2006). This association is dependent on the arginine/lysine-rich
motifs close to the polyQ tract of ataxin-3 (Boeddrich et al., 2006),
and several reports point to a stronger interaction with the disease-
protein containing longer polyQ stretches (Wang et al., 2000;
Matsumoto et al., 2004; Boeddrich et al., 2006; Zhong and Pittman,
2006). Functional interaction with VCP/p97 is able to modulate
the fibrillogenesis of a C-terminal fragment of expanded ataxin-3
(71Q) in a concentration-dependent manner, with equimolar con-
centrations of VCP/p97 stimulating fibrillogenesis, while a four-
fold excess of VCP prevented aggregation (Boeddrich et al., 2006).
This study provides clues toward the role of interactors targeting
the C-terminal region of ataxin-3 as modulators of its oligomer-
ization properties, indicating that this mostly unstructured region
(Masino et al., 2003; Scarff et al., 2012) may also represent a bridge
between physiological interactions, function, and aggregation. In
the field of polyQ disorders, the search for protein interactors
is an active area of research, uncovering novel macromolecular
partners often acting as disease modifiers (Goehler et al., 2004;
Kaltenbach et al., 2007; McGurk and Bonini, 2012). A recent screen
for modifiers of ataxin-1 aggregation and toxicity in mammalian
cells showed that toxicity enhancers often contained coiled-coil
domains. Importantly, coiled-coil formation by ataxin-3 polyQ
stretch and its flanking domains were also predicted (Fiumara
et al., 2010), however neither the consequences of its expansion
nor its functional properties were experimentally assessed. Since
coiled-coil structures are known to be involved in protein–protein
interactions (Parry et al., 2008; Fiumara et al., 2010), it would be
interesting to access the role of protein interactions mediated by
the polyQ region of ataxin-3 in regulating its aggregation behav-
ior (Figure 4). In fact, some of the interactors associated with
ataxin-3 nuclear functions, rich in polyQ- (p300, NCOR, CBP),
and polyA-repeats (NCOR), target this region and are predicted
to bind better to the expanded protein (Figures 4 and 5). There-
fore it is tempting to speculate that these anomalously stronger
interactions with the expanded protein in the nucleus might be
associated with increased aggregation and toxicity observed when
a strong nuclear localization sequence (NLS) is fused to ataxin-
3 (Perez et al., 1998; Bichelmeier et al., 2007; Macedo-Ribeiro
et al., 2009) or when the protein shuttles to the nucleus upon
increased cellular stress (Reina et al., 2010). Heat-shock induces
phosphorylation of a serine residue located on ataxin-3 JD and dri-
ves the protein to the nucleus leading to its dissociation from the
cytosolic VCP/HHR23A complex (Reina et al., 2010), highlighting
the dynamic nature of ataxin-3 partition between macromolec-
ular assemblies and making it tempting to speculate that polyQ
expansion might affect this distribution.
CONCLUDING REMARKS
Trinucleotide repeats are keen for driving evolution by provid-
ing genetic variability, with homopeptide-encoded regions being
crucial for the establishment of protein interactions. However, as
unstable regions, expansion of the homopeptide regions might
occur, being responsible for several neurodegenerative and muscu-
lar diseases. Homopeptide repeats such as polyQ and polyA seem
to influence and to drive the repeat-containing protein toward self-
assembly and aggregation. On the other hand, structural studies
were able to reveal that aggregation of homopeptide-containing
proteins also depends on the homopeptide protein context with
additional protein domains playing a role in a multi-domain self-
assembly mechanism. Differential expression of protein isoforms
generated by alternative splicing, post-translational modifications
and, additionally, differences in macromolecular interactions are
currently advanced as hypotheses that, by their ability to modulate
protein function and aggregation, could explain the cell-specific
toxicity of the homopeptide-expanded proteins.
Ataxin-3 is an excellent example of a repeat-containing protein
that, upon polyQ-expansion, does not undergo drastic struc-
tural and functional changes, but achieves an increased ten-
dency toward self-assembly and aggregation. The protein has
deubiquitinase activity and plays a role in the cell-quality con-
trol system, and in transcriptional regulation. As a result of its
modular multi-domain structure, ataxin-3 engages in multiple
macromolecular interactions and several evidences show that
it associates with several functional multiprotein complexes, in
some cases in a polyQ-dependent manner. The structural and
mechanistic details regulating ataxin-3 redistribution between
different cellular machineries are still unclear, although post-
translational modifications of the protein subunits assembled in
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these complexes are likely to play a role. Different cellular events
such as proteotoxic stress or aging might unbalance the association
of expanded ataxin-3 with its molecular partners and contribute
to the alteration of ataxin-3 normal cellular functions. Since
ataxin-3 self-assembly is a complex process that involves several
protein domains, including JD, the relocalization of the protein
to different complexes might induce the exposure of aggregation-
prone regions and lead to the appearance of the characteristic
intracellular protein inclusions.
Since macromolecular interactions seem to be either protec-
tive or exacerbate aggregation of the homopeptide-containing
proteins, they might be targeted therapeutically. However, an in-
depth understanding about the effect of homopeptide-expansion
in the function of the containing-protein and on the interactions
with molecular partners is required, in order to understand how
they contribute to neurodegeneration. The combination of bio-
chemical and computational approaches to the identification of
disease-protein interaction networks is critical for defining their
normal function, identifying new markers for disease prognosis
and also for the development of tools to selectively target those
interactions with potentially reduced side effects.
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